You searched for "complaints"

1372 results found

Could idebenone by the solution for treating dominant optic atrophy?

Dominant optic atrophy (DOA) is a disease of the retinal ganglion cells, with no current treatment options. In most cases, DOA is caused by a mutation in the OPA1 gene. The aim of this study was to evaluate the effect...

Implementing technology to improve global eye health

Technological innovation is providing new solutions to transform global eye health [1–5]. In particular, research towards the development of artificial intelligence (AI) tools in ophthalmology has gained pace in recent years. However, there has been little research relating to its...

Report: UKEGS 2024

It was an incredible experience heading down to UKEGS 2024 earlier this month in Southampton. The entire Glaucoma UK team, along with the UKEGS overseeing panel Nishani Amerasinghe, Andrew Tatham, Professir Anthony King and Professor Gus Gazzard, took great care...

The results of the last survey Feb24

Thank you to all those who participated in this edition’s survey and for those of you who attended my recent Medico-legal Seminar at the Royal College of Ophthalmologists. It was a fascinating and educational day, made a success by the...

A missed intraocular telescope – an opportunity to re-focus the evidence

Intraocular telescopes allow magnification of the image so that it would be projected into a larger area of the macula, this makes the central defect caused by dry age-related macular degeneration (AMD) smaller. The most common approach is a Galilean...

Anatomical Three-dimensional Orbital ModelS (ATOMS) in Ophthalmology Education

Our educational aim is to provide a simple blended learning solution to ophthalmology trainees centered around Anatomical Three-dimensional Orbital ModelS (ATOMS) to help teach orbital anatomy and make it simple to learn.

The College of Optometrists publishes updated Clinical Governance Guidance to support quality improvement and excellence in optometry

The College of Optometrists has launched its updated Clinical Governance Guidance to provide members with a robust framework that aligns with the healthcare landscape and primary care optometry workplace practices of today - and into the future. The guidance will...

Green Charter inspires the Optical Community

Green Charter – the optical community’s clear pathway for a sustainable future – attracted great interest at 100% Optical, with businesses keen to learn more about specific guidance. Launched by Opticare Innovations, the commercial arm of the OSA, the five...

Glaucoma medications and ocular surface disease

This literature review examined ocular surface disease (OSD) associated with glaucoma medication. The authors examined the prevalence of features and management guidelines glaucoma medication associated OSD. Fifty-eight articles published within the past five years are included in this review and...

Oertli Instrumente AG achieves milestone with FDA 510(k) clearance for Faros surgical system

Oertli Instrumente AG, a leader in innovative surgical solutions for ophthalmology, is proud to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance for the worldwide established Faros anterior cataract surgery system. This milestone underscores Oertli's global reach and...

Moorfields earns UK’s first UKAS accreditation for ophthalmic and vision science (IQIPS)

The United Kingdom Accreditation Service (UKAS) has granted the first accreditation for Ophthalmic and Vision Science to Moorfields Eye Hospital. The award was made to the Electrophysiology Department at Moorfields under the Improving Quality In Physical Services (IQIPS) programme.

OrCam MyEye – innovative sight assistance (Part 1)

For Jun/Jul 20201 and Aug/Sep 2021 we have a two-part review (see Part 2 here) of an innovative piece of sight impairment technology. The device is called a MyEye, made by OrCam. I was given the opportunity to use the...